FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study EB613 Phase 2 Data Demonstrating Consistent ...
5d
VA Tech Wabag Ltd (BOM:533269) Q2 2026 Earnings Call Highlights: Strategic Growth and Financial ...
VA Tech Wabag Ltd (BOM:533269) showcases strong financial positioning and strategic expansion plans, while addressing operational challenges and legal hurdles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback